Chunshan Wei

425 total citations
20 papers, 300 citations indexed

About

Chunshan Wei is a scholar working on Epidemiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Chunshan Wei has authored 20 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Chunshan Wei's work include Liver Disease Diagnosis and Treatment (8 papers), Phytochemistry and Bioactivity Studies (6 papers) and Hepatitis B Virus Studies (6 papers). Chunshan Wei is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Phytochemistry and Bioactivity Studies (6 papers) and Hepatitis B Virus Studies (6 papers). Chunshan Wei collaborates with scholars based in China, Denmark and Macao. Chunshan Wei's co-authors include Henning Grønbæk, Karen Louise Thomsen, Filip K. Knop, Tea Lund Laursen, Konstantin Kazankov, Guangdong Tong, Yufeng Xing, Xiaoyan Jiang, Xiang Cui and Naja Becher and has published in prestigious journals such as PLoS ONE, World Journal of Gastroenterology and Frontiers in Pharmacology.

In The Last Decade

Chunshan Wei

18 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunshan Wei China 10 165 76 73 72 54 20 300
Lianjun Xing China 12 154 0.9× 53 0.7× 142 1.9× 47 0.7× 75 1.4× 23 357
Jiacheng Shen China 12 175 1.1× 63 0.8× 121 1.7× 102 1.4× 89 1.6× 28 479
Juan Zhao China 11 81 0.5× 55 0.7× 84 1.2× 72 1.0× 23 0.4× 33 318
Shengliang Xin China 9 239 1.4× 57 0.8× 164 2.2× 24 0.3× 64 1.2× 12 409
A. Provenzano Italy 9 222 1.3× 144 1.9× 72 1.0× 47 0.7× 63 1.2× 15 379
Han-Chieh Lin Taiwan 12 83 0.5× 92 1.2× 121 1.7× 79 1.1× 15 0.3× 24 344
Virginia Gutiérrez‐de Juan Spain 7 129 0.8× 66 0.9× 181 2.5× 50 0.7× 27 0.5× 8 369
Yun-Cheng Hsieh Taiwan 13 167 1.0× 132 1.7× 66 0.9× 49 0.7× 42 0.8× 18 311
Yuting Li China 10 133 0.8× 36 0.5× 111 1.5× 41 0.6× 75 1.4× 23 340

Countries citing papers authored by Chunshan Wei

Since Specialization
Citations

This map shows the geographic impact of Chunshan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunshan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunshan Wei more than expected).

Fields of papers citing papers by Chunshan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunshan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunshan Wei. The network helps show where Chunshan Wei may publish in the future.

Co-authorship network of co-authors of Chunshan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chunshan Wei. A scholar is included among the top collaborators of Chunshan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunshan Wei. Chunshan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Chunshan, et al.. (2025). Integrating Network Pharmacology and In Vitro Experiments for Assessing the Anti-Tumor Effects of Phyllanthus Urinaria L Anti-neoplastic Decoction in Hepatocellular Carcinoma.. PubMed. 31(3). 114–121.
2.
Wang, Ping, Meifang Li, Mingshun Li, et al.. (2024). A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma. Frontiers in Pharmacology. 15. 1443667–1443667. 7 indexed citations
3.
4.
Wei, Chunshan, Peter Holland‐Fischer, Kurt Kristensen, et al.. (2022). Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease. European Journal of Pediatrics. 182(2). 855–865. 4 indexed citations
5.
Tong, Guangdong, Weichao Zhong, Xiaoyan Jiang, et al.. (2022). Association of reduced renal function with different phase of chronic hepatitis B virus infection. 1.
6.
Wei, Chunshan, et al.. (2022). In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine. 2022. 1–30. 6 indexed citations
7.
Jiang, Xiaoyan, Bing Huang, Chunshan Wei, et al.. (2021). Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy. World Journal of Gastroenterology. 27(11). 1101–1116. 9 indexed citations
8.
Wei, Chunshan, et al.. (2021). Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 9 indexed citations
9.
Cui, Xiang, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, & Guangdong Tong. (2020). Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis. Environmental Toxicology and Pharmacology. 78. 103397–103397. 32 indexed citations
10.
Wei, Chunshan, et al.. (2020). New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report. World Journal of Gastroenterology. 26(5). 550–561. 24 indexed citations
11.
Li, Yun, Mingjie Jiang, Mingshun Li, et al.. (2019). Compound Phyllanthus urinaria L Inhibits HBV-Related HCC through HBx-SHH Pathway Axis Inactivation. Evidence-based Complementary and Alternative Medicine. 2019. 1–15. 13 indexed citations
12.
Laursen, Tea Lund, Chunshan Wei, Konstantin Kazankov, et al.. (2019). Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. World Journal of Hepatology. 11(2). 138–149. 122 indexed citations
13.
Xu, Tianqi, et al.. (2019). Phenolic Constituents with Antioxidant and Antiviral Activities from Phyllanthus urinaria Linnea. Indian Journal of Pharmaceutical Sciences. 81(3). 9 indexed citations
14.
15.
Zhang, Li, Chunshan Wei, Yunjun Ruan, et al.. (2018). Serum containing Buyang Huanwu decoction prevents age-associated migration and invasion of human vascular smooth muscle cells by up regulating SIRT1 expression. BioScience Trends. 12(3). 282–290. 9 indexed citations
16.
Wei, Chunshan, et al.. (2013). Two new acetylated flavonoid glycosides fromPhyllanthus urinaria. Journal of Asian Natural Products Research. 15(7). 703–707. 5 indexed citations
17.
Tong, Guangdong, et al.. (2013). Efficacy of early treatment on 52 patients with preneoplastic hepatitis B virus-associated hepatocellular carcinoma by compound Phyllanthus Urinaria L.. Chinese Journal of Integrative Medicine. 20(4). 263–271. 15 indexed citations
18.
Tong, Guangdong, Haihong Tang, Chunshan Wei, et al.. (2012). Efficacy of ursodeoxycholic acid combined with Tongdan Decoction (通胆汤) on immunological indices and histopathological changes in primary biliary cirrhosis patients. Chinese Journal of Integrative Medicine. 18(1). 16–22. 8 indexed citations
19.
Tong, Guangdong, Chunshan Wei, Yufeng Xing, et al.. (2011). [Clinical outcomes of long-term anti-inflammatory and hepatoprotective treatments in patients with chronic hepatitis B].. PubMed. 19(9). 701–3. 1 indexed citations
20.
Chen, Xiaoyin, et al.. (2007). [Preventive and therapeutic effects of qiongyugao on hepatocellular carcinoma via inhibition of the expression of HBxAg in hepatic carcinoma cells].. PubMed. 23(1). 56–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianjun Xing Breakdown of academic impact, for papers by Jiacheng Shen Breakdown of academic impact, for papers by Juan Zhao Breakdown of academic impact, for papers by Shengliang Xin Breakdown of academic impact, for papers by A. Provenzano Breakdown of academic impact, for papers by Han-Chieh Lin Breakdown of academic impact, for papers by Virginia Gutiérrez‐de Juan Breakdown of academic impact, for papers by Yun-Cheng Hsieh Breakdown of academic impact, for papers by Yuting Li
Rankless by CCL
2026